Bionor Pharma is a leading vaccine company, searching for breakthrough treatments for HIV and other deadly viruses.

Modified Peptide based vaccinesen/Vaccines_+_technology/Platform_technology/The key to kill virusen/Vaccines_+_technology/Platform_technology/Vacc-4x kills virus producing cells.en/Vaccines_+_technology/HIV_vaccine_Vacc-4x/

Latest news

Hide mandatory notifications of trade

Invitation to Annual General Meeting 14 May 2014

Financial .2014

Oslo, 23 April 2014 - The Annual General Meeting of Bionor Pharma ASA will be held on Wednesday 14 May 2014, 10:00 a.m. at Kronprinsesse Marthas Plass 1, Oslo

Bionor Pharma Announces Completion of Enrollment of Part A of REDUC trial

Scientific .2014

(Oslo 1 April, 2014) Bionor Pharma ASA (OSE: BIONOR) announced today the completion of enrollment of patients for part A of the Phase I/II REDUC study.

Invitation to Annual General Meeting 14 May 2014

Financial .2014

Oslo, 23 April 2014 - The Annual General Meeting of Bionor Pharma ASA will be held on Wednesday 14 May 2014, 10:00 a.m. at Kronprinsesse Marthas Plass 1, Oslo

Bionor Pharma Announces Completion of Enrollment of Part A of REDUC trial

Scientific .2014

(Oslo 1 April, 2014) Bionor Pharma ASA (OSE: BIONOR) announced today the completion of enrollment of patients for part A of the Phase I/II REDUC study.

Go to news section

Featured content